The FDA recently announced that the national shortage of semaglutide and tirzepatide is over and has notified compounding pharmacies that they must stop manufacturing these medications by May 2025
If needed, you can keep the medication between 59F and 86F (15C and 30C)
The most common stacks we see at BlueWater Wellness include: Semaglutide + BPC-157: The GLP-1 drives fat loss while BPC-157 supports GI tolerance and gut health
This was not ideal given the need to know as soon as possible if people were infected so that appropriate precautions could be taken to prevent its transmission to others and treatment started
1 2 3 4 Clinical pediatric dermatology
GLP-1 receptor agonists, now established as an extremely potent therapy for managing type 2 diabetes and obesity, are based on gut-derived peptides, and have profound, albeit variable, effects to slow gastric emptying